Monoclonal Antibody Therapy Market trends, Industry Top Leaders, Comprehensive Analysis, Devices Type, Regional Segments, Innovation and Forecast to 2027

The global monoclonal antibody therapy market size was USD 157.33 billion in 2020. The market is projected to grow from USD 178.50 billion in 2021 to USD 451.89 billion in 2028 at a CAGR of 14.1% in the 2021-2028 period. This information is published by Fortune Business Insights™ in its report titled, “Monoclonal Antibody Therapy Market, 2021-2028.” As per our researchers, escalating research and development subsidy for the development and upgrading of fresh monoclonal antibodies is projected to strengthen the market during the mentioned timeframe. The present giant companies in the market are constantly rooting for novel innovations and providing authorized drugs for the betterment of society. For instance, in December 2019, CARsgen Therapeutics was granted Investigational New Drug (IND) approval for AB011 in China, which is a civilized monoclonal antibody for treating gastrointestinal and pancreatic adenocarcinoma.

Request Sample Report:

Report Coverage

We offer an all-inclusive study of the monoclonal antibody therapy market along with current trends and future anticipations to establish proximate investment gains. Also presented in the report is an in-depth analysis of any possible opportunities, dangers, oppositions, or driving factors. We have conducted a systematic regional analysis for better comprehension of the global market size, share, and structure. The COVID-19 impacts have been provided to help stakeholders and business owners to invest their money carefully at the right time. The key players in the market are acknowledged, and their schemes to boost the growth of the market are revealed in the report.


Based on type, the market is segregated into human monoclonal antibody, humanized, monoclonal antibody, chimeric monoclonal antibody, and murine monoclonal antibody. The human monoclonal antibody segment was responsible for the leading position. This can be accredited to the augmented sales and demand for Humira.

On the basis of application, the market is classified into type cancer, autoimmune diseases, and others. Based on the distribution channel, the market is categorized into hospital pharmacy, retail pharmacy, and online pharmacy. In terms of geography, the market is segregated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

List of Key Players Covered in the Report

  • AbbVie Inc.
  • Merck & Co., Inc.
  • Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Daiichi Sankyo Company, Limited
  • Novartis AG
  • Alexion Pharmaceuticals, Inc.
  • Amgen Inc.

Related Reports:

ePharmacy Market Demand

ePharmacy Market Key Players

ePharmacy Market Business Opportunities

ePharmacy Market Analysis

ePharmacy Market Growth

ePharmacy Market Trends

ePharmacy Market Share

ePharmacy Market Size

ePharmacy Market

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune -411045, Maharashtra, India.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Leave a Reply

Your email address will not be published. Required fields are marked *